Skip to main content
. Author manuscript; available in PMC: 2012 Sep 23.
Published in final edited form as: Neuropharmacology. 2009 Jan 21;56(5):886–895. doi: 10.1016/j.neuropharm.2009.01.013

Figure 8.

Figure 8

EtOH enhancement of mIPSC frequency is reduced by pretreatment with a GABAB agonist. A) Top, mIPSCs recorded from a representative cell during control conditions and during EtOH application. Bottom, bar graph summarizing the effect of EtOH on mIPSC frequency, amplitude, and decay. B) Top, mIPSCs recorded from a representative cell during control, 1 μM baclofen, and during baclofen + EtOH conditions. Bottom, bar graph summarizing the effect of baclofen + EtOH on mIPSC frequency, amplitude, and decay. Between 8–11 cells were used in each group.*, significant difference from control conditions (p < 0.05).